Establishment of NAFLD Cohort and Development of Fibrosis Markers
This study is designed for establishment of non-alcoholic fatty liver disease patients cohort to development of markers to predict histologic progression of liver fibrosis.
| Condition(s) | Fibrosis of Liver |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | This study is designed for establishment of non-alcoholic fatty liver disease patients cohort to development of markers to predict histologic progression of liver fibrosis. |
| Who can participate | Inclusion Criteria: * Patients with histologically confirmed fatty liver disease * Patients with radiologically confirmed fatty liver disease Exclusion Criteria: * History of significant alcohol consumption * Viral hepatitis * Autoimmune hepatitis * Metabolic diseases (e.g. hemochromatosis, M. Wilson, alpha 1-antitrypsin deficiency) * Hepatotoxic medication (e.g. amiodarone) |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Seoul National University Boramae Hospital |
| Locations | Seoul, South Korea |
| Start date | 2014-01-01 |
| NCT ID | NCT02206841 |
| Official listing | https://clinicaltrials.gov/study/NCT02206841 |